Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction
Status:
Not yet recruiting
Trial end date:
2023-03-30
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, placebo-controlled, two-cohort, three-cycle
crossover (at least a 5-day cleaning period per cycle), and a multicenter clinical trial
design.